Utmost Group has announced the sale of its bulk purchase annuity (BPA) business, Utmost Life and Pensions, to JAB Insurance. The sale, which is subject to regulatory approval, encompasses the entire ...

MIAMI--(BUSINESS WIRE)--JAB Insurance today announced that it has entered into a definitive agreement to acquire from Utmost Group plc its Life and Pensions business (“ULP”), a UK life and pensions ...

Police notices to Telangana's two biggest opposition leaders – Bharat Rashtra Samithi chief K Chandrasekhar Rao and his son, the party's Working President, KT Rama Rao – have been received with ...

AstraZeneca gains exclusive global rights to JAB-23E73, except in China, where it collaborates with Jacobio. JAB-23E73 shows potent pan-KRAS inhibition, sparing HRAS and NRAS, with promising antitumor ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once touted as a future blockbuster – after it failed the Phase 3 CMVictory trial ...

Moderna's mRNA-based pandemic flu vaccine – which had federal funding pulled earlier this year amid an increasingly vaccine-sceptic stance by the Trump administration – has been thrown a lifeline by ...

A pill version of blockbuster slimming drug Wegovy got the green light from US health chiefs last night, with the daily tablet expected to be launched in America in January. The approval marks the ...

At this rate, the first Subway Series of 2026 is going to double as a family reunion. With Luke Weaver becoming the latest to sign with the Mets this week, joining Devin Williams this offseason and ...

BEIJING, SHANGHAI and BOSTON, Dec. 21, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK,) today announced that it has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73 ...

The current batch of COVID-19 vaccines effectively prevents severe disease and death and offers substantial protection against the variants. But the authorized vaccines are not 100 percent effective ...